• Interaction Score: 2.36

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy AEB071 + CGM097
    Indication/Tumor Type uveal melanoma
    Response Type predicted – sensitive

    PMIDs:
    27507190


    Sources:
    JAX-CKB

  • Interaction Score: 1.64

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy AEB071 + CGM097
    Indication/Tumor Type uveal melanoma
    Response Type predicted – sensitive

    PMIDs:
    27507190


    Sources:
    JAX-CKB

  • Interaction Score: 0.22

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Approval Status Preclinical - Cell culture
    Indication/Tumor Type colorectal cancer
    combination therapy ABT-263 + CGM097 + Dabrafenib + PF-04217903

    PMIDs:
    27659046


    Sources:
    JAX-CKB

  • Interaction Score: 0.16

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy ABT-263 + Alpelisib + CGM097 + Trametinib
    Indication/Tumor Type colorectal cancer
    Response Type sensitive

    PMIDs:
    27659046


    Sources:
    JAX-CKB

  • Interaction Score: 0.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy CGM097 + Trametinib
    Indication/Tumor Type colorectal cancer
    Response Type sensitive

    PMIDs:
    27659046


    Sources:
    JAX-CKB

  • Interaction Score: 0.08

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy ABT-263 + Alpelisib + CGM097 + Trametinib
    Approval Status Preclinical - Cell culture
    Indication/Tumor Type colorectal cancer

    PMIDs:
    27659046


    Sources:
    JAX-CKB TTD